News Ionis brings long-acting treatment option to HAE patients Ionis gets FDA nod for its HAE attack prophylactic treatment Dawnzera, offering less frequent dosing than its rivals.
News EU-US trade deal includes 15% pharma tariff Details have been published of the trade agreement between the US and EU, with confirmation of the tariff rates for pharmaceuticals.
News J&J earmarks $2bn for facility in North Carolina Johnson & Johnson has filled in some of the detail in its $55 billion investment in US facilities announced earlier this year.
News Iterum brings first oral penem antibiotic to US market Iterum has launched Orlynvah as a treatment for uncomplicated urinary tract infections (uUTIs), the first oral option in the go-to penem class.
News PTC stung by FDA decision not to approve rare disease drug It looks like PTC will have to carry out another trial of its drug for Friedreich ataxia before the FDA will consider approval.
News CSL will slash headcount and hive off vaccine business Facing declines in flu vaccination rates in the US, CSL will spin out its vaccine unit as part of a wider restructuring that will claim 3,000 jobs.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
